1. Home
  2. VRAX
  3. VRAX News

Latest Virax Biolabs Group Limited (VRAX) News on September 18, 2025

Virax Biolabs' Investigational Diagnostic Tests Has An Attractive Market Opportunity', Analyst Initiates With Buy Rating
VRAX

Benzinga

6 months ago

Virax Biolabs' Investigational Diagnostic Tests Has An Attractive Market Opportunity', Analyst Initiates With Buy Rating

Virax Biolabs Enrolls First Patients in Clinical Study Assessing T cell Dysfunction in Post-acute Infection Syndromes
VRAX

PR Newswire

6 months ago

Virax Biolabs Enrolls First Patients in Clinical Study Assessing T cell Dysfunction in Post-acute Infection Syndromes

Virax Biolabs Presents Data on T-Cell Dysfunction in Post-acute Infection Syndromes at the 19th World Immune Regulation Meeting
VRAX

PR Newswire

6 months ago

Virax Biolabs Presents Data on T-Cell Dysfunction in Post-acute Infection Syndromes at the 19th World Immune Regulation Meeting

Virax Biolabs to Present at 19th World Immune Regulation Meeting
VRAX

PR Newswire

6 months ago

Virax Biolabs to Present at 19th World Immune Regulation Meeting

Virax Biolabs Believes Technology Aligns with United States Department of Health and Human Services' Transparency Priority on Vaccine Efficacy
VRAX

PR Newswire

7 months ago

Virax Biolabs Believes Technology Aligns with United States Department of Health and Human Services' Transparency Priority on Vaccine Efficacy

EXCLUSIVE: Virax Biolabs Says Its Tech Fits RFK Jr.'s HHS Goals On Vaccine Transparency
VRAX

Benzinga

7 months ago

EXCLUSIVE: Virax Biolabs Says Its Tech Fits RFK Jr.'s HHS Goals On Vaccine Transparency

Cosmos Health secures exclusive distribution agreement with Virax Biolabs
VRAX

TipRanks

8 months ago

Cosmos Health secures exclusive distribution agreement with Virax Biolabs

VRAX

MT Newswires

8 months ago

Cosmos Health to Distribute Virax Avian Influenza PCR Kits in Europe, GCC Countries

Virax Biolabs' CEO James Foster Issues Letter to Shareholders
VRAX

PR Newswire

9 months ago

Virax Biolabs' CEO James Foster Issues Letter to Shareholders

Virax Biolabs Announces Agreement with Tebubio to Expand Distribution of ImmuneSelect Across the European Union, Norway, and Switzerland
VRAX

PR Newswire

9 months ago

Virax Biolabs Announces Agreement with Tebubio to Expand Distribution of ImmuneSelect Across the European Union, Norway, and Switzerland

VRAX

MT Newswires

a year ago

Top Midday Gainers

Virax Biolabs Announces Distribution Agreement with Europa Biosite to Commercialize ImmuneSelect in the United Kingdom and Ireland
VRAX

PR Newswire

a year ago

Virax Biolabs Announces Distribution Agreement with Europa Biosite to Commercialize ImmuneSelect in the United Kingdom and Ireland

EXCLUSIVE: Virax Biolabs Inks Distribution Pact To Commercialize ImmuneSelect Profiling Solutions In UK And Ireland
VRAX

Benzinga

a year ago

EXCLUSIVE: Virax Biolabs Inks Distribution Pact To Commercialize ImmuneSelect Profiling Solutions In UK And Ireland

VRAX

MT Newswires

a year ago

Cosmos Health Signs Deal to Distribute Virax Biolabs' Mpox PCR Detection Kits in India

VRAX

MT Newswires

a year ago

Virax Biolabs Extends Exclusive Distribution Deal for Mpox Virus Test Kits; Shares Rise Pre-Bell

Virax Biolabs Announces Extension of Existing Exclusive Distribution Agreement to Market Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits with Cosmos Health Inc.
VRAX

PR Newswire

a year ago

Virax Biolabs Announces Extension of Existing Exclusive Distribution Agreement to Market Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits with Cosmos Health Inc.

Virax Biolabs Presents at H.C. Wainwright's 26th Annual Global Investment Conference
VRAX

PR Newswire

a year ago

Virax Biolabs Presents at H.C. Wainwright's 26th Annual Global Investment Conference

Virax Biolabs to Participate at 7th European Congress of Immunology
VRAX

PR Newswire

a year ago

Virax Biolabs to Participate at 7th European Congress of Immunology

VRAX

MT Newswires

a year ago

Sector Update: Health Care

VRAX

MT Newswires

a year ago

Virax Biolabs to Distribute Mpox Detection Kits Across Europe, GCC

Virax Biolabs Announces Distribution Agreement to Commercialize Mpox (formerly Monkeypox) Virus RT-PCR Detection Kits in Europe and the Middle East
VRAX

PR Newswire

a year ago

Virax Biolabs Announces Distribution Agreement to Commercialize Mpox (formerly Monkeypox) Virus RT-PCR Detection Kits in Europe and the Middle East

EXCLUSIVE: Virax Biolabs Inks Distribution Pact For Mpox Diagnostic Kits In Europe And Middle East
VRAX

Benzinga

a year ago

EXCLUSIVE: Virax Biolabs Inks Distribution Pact For Mpox Diagnostic Kits In Europe And Middle East

VRAX

MT Newswires

a year ago

Virax Biolabs Closes $5 Million Direct Offering of Shares

Virax Biolabs Group Limited Announces Closing of $5 Million Registered Direct Offering of Ordinary Shares
VRAX

PR Newswire

a year ago

Virax Biolabs Group Limited Announces Closing of $5 Million Registered Direct Offering of Ordinary Shares

VRAX

MT Newswires

a year ago

Virax Biolabs Group Signs Deal for $5 Million Share Offering

Virax Biolabs Group Limited Announces $5 Million Registered Direct Offering of Ordinary Shares
VRAX

PR Newswire

a year ago

Virax Biolabs Group Limited Announces $5 Million Registered Direct Offering of Ordinary Shares

VRAX

MT Newswires

a year ago

Cosmos Health Signs Manufacturing Deal with Provident; Firm Holds EU Distribution Rights for Mpox Detection Kits

Zacks Investment Ideas feature highlights: Virax Biolabs Group, GeoVax Labs, Applied DNA Sciences and Emergent BioSolutions
VRAX

Zacks

a year ago

Zacks Investment Ideas feature highlights: Virax Biolabs Group, GeoVax Labs, Applied DNA Sciences and Emergent BioSolutions

VRAX

MT Newswires

a year ago

Top Premarket Gainers

EXCLUSIVE: Virax Biolabs Launches Immune Profiling Solutions To Evaluate Adaptive Immunity In Post-Viral Syndromes
VRAX

Benzinga

a year ago

EXCLUSIVE: Virax Biolabs Launches Immune Profiling Solutions To Evaluate Adaptive Immunity In Post-Viral Syndromes

Virax Biolabs Launches Portfolio of Immune Profiling Solutions Evaluating Adaptive Immunity in Post-Viral Syndromes at ESCMID Global 2024
VRAX

PR Newswire

a year ago

Virax Biolabs Launches Portfolio of Immune Profiling Solutions Evaluating Adaptive Immunity in Post-Viral Syndromes at ESCMID Global 2024

Virax Biolabs to Participate at ESCMID Global 2024
VRAX

PR Newswire

a year ago

Virax Biolabs to Participate at ESCMID Global 2024

Virax Biolabs Announces Receipt of NASDAQ Notification Letter Regarding Minimum Bid Price Deficiency
VRAX

PR Newswire

2 years ago

Virax Biolabs Announces Receipt of NASDAQ Notification Letter Regarding Minimum Bid Price Deficiency

Cemtrex Receives $0.8 Million Additional Vicon Industries Order from School District Customer
VRAX

GlobeNewswire

2 years ago

Cemtrex Receives $0.8 Million Additional Vicon Industries Order from School District Customer

Altamira Therapeutics Files Second Provisional Patent Application for OligoPhore Nanoparticles Targeting Different KRAS Mutations in Cancer Treatment
VRAX

GlobeNewswire

2 years ago

Altamira Therapeutics Files Second Provisional Patent Application for OligoPhore Nanoparticles Targeting Different KRAS Mutations in Cancer Treatment

Digital Ally Announces University Security Order
VRAX

GlobeNewswire

2 years ago

Digital Ally Announces University Security Order

Peraso Announces First Commercial Order Utilizing DUNE Platform in Dense Urban Environments
VRAX

ACCESSWIRE

2 years ago

Peraso Announces First Commercial Order Utilizing DUNE Platform in Dense Urban Environments

S&W Seed Company to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference on February 1, 2024
VRAX

PR Newswire

2 years ago

S&W Seed Company to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference on February 1, 2024

MAIA Soars 20% on Interim Results From Lung Cancer Study
VRAX

Zacks

2 years ago

MAIA Soars 20% on Interim Results From Lung Cancer Study

Biotech Commercialization Leader, Amy Mahery, to Join CNS Pharmaceuticals Board of Directors
VRAX

ACCESSWIRE

2 years ago

Biotech Commercialization Leader, Amy Mahery, to Join CNS Pharmaceuticals Board of Directors

CNS Pharmaceuticals Achieves Completion of Planned Enrollment in Potentially Pivotal Study of Berubicin for the Treatment of Glioblastoma Multiforme (GBM)
VRAX

ACCESSWIRE

2 years ago

CNS Pharmaceuticals Achieves Completion of Planned Enrollment in Potentially Pivotal Study of Berubicin for the Treatment of Glioblastoma Multiforme (GBM)

Marti Announces up to $2.5M Share Repurchase Program
VRAX

Business Wire

2 years ago

Marti Announces up to $2.5M Share Repurchase Program

Innovative Eyewear, Inc. Receives Notice of Allowance for Fourteen Patent Applications
VRAX

PR Newswire

2 years ago

Innovative Eyewear, Inc. Receives Notice of Allowance for Fourteen Patent Applications

Earlyworks Co., Ltd. Entered into a Memorandum of Understanding with Social Finance Limited for Blockchain Game Development
VRAX

GlobeNewswire

2 years ago

Earlyworks Co., Ltd. Entered into a Memorandum of Understanding with Social Finance Limited for Blockchain Game Development

Vicinity Motor Corp. Announces VMC 1200 Distribution Agreement with Shift EV Trucks in West Toronto, Canada
VRAX

ACCESSWIRE

2 years ago

Vicinity Motor Corp. Announces VMC 1200 Distribution Agreement with Shift EV Trucks in West Toronto, Canada

Vicinity Motor Corp. Issues DSUs
VRAX

ACCESSWIRE

2 years ago

Vicinity Motor Corp. Issues DSUs

Innovative Eyewear, Inc. and IngenioSpec LLC Announce License Agreement
VRAX

PR Newswire

2 years ago

Innovative Eyewear, Inc. and IngenioSpec LLC Announce License Agreement

VRAX

Business Wire

2 years ago

NUBURU Announces Notice of Noncompliance with NYSE American Listing Standards

Nuwellis Receives FDA Clearance for an Additional Dual Lumen Extended Length Peripheral Catheter
VRAX

GlobeNewswire

2 years ago

Nuwellis Receives FDA Clearance for an Additional Dual Lumen Extended Length Peripheral Catheter

Eiger BioPharmaceuticals, Inc. Announces 1-for-30 Reverse Stock Split
VRAX

PR Newswire

2 years ago

Eiger BioPharmaceuticals, Inc. Announces 1-for-30 Reverse Stock Split

KELLY RENTZEL NAMED NEW GENERAL COUNSEL FOR LANDSEA HOMES
VRAX

PR Newswire

2 years ago

KELLY RENTZEL NAMED NEW GENERAL COUNSEL FOR LANDSEA HOMES

ELEVAI LABS, Inc. to Participate in Upcoming Aesthetic Industry Conferences
VRAX

GlobeNewswire

2 years ago

ELEVAI LABS, Inc. to Participate in Upcoming Aesthetic Industry Conferences

Canadian Investment Regulatory Organization Trade Resumption - DGHI
VRAX

CNW Group

2 years ago

Canadian Investment Regulatory Organization Trade Resumption - DGHI

LANDSEA HOMES LAUNCHES FIRST ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT
VRAX

PR Newswire

2 years ago

LANDSEA HOMES LAUNCHES FIRST ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT

Avalo Therapeutics Announces 1-for-240 Reverse Stock Split
VRAX

GlobeNewswire

2 years ago

Avalo Therapeutics Announces 1-for-240 Reverse Stock Split

Topline Results from MYLOX-1 Trial Demonstrate Reduction in Fibrosis of the Bone Marrow in Patients with Myelofibrosis
VRAX

GlobeNewswire

2 years ago

Topline Results from MYLOX-1 Trial Demonstrate Reduction in Fibrosis of the Bone Marrow in Patients with Myelofibrosis

Treasure Global Launches 10 Mini Games Integrated with AI Game Creator in ZCITY’s 3D World, Enters Booming Global Gaming Market
VRAX

GlobeNewswire

2 years ago

Treasure Global Launches 10 Mini Games Integrated with AI Game Creator in ZCITY’s 3D World, Enters Booming Global Gaming Market

Brenmiller Energy See Massive Potential for U.S. Thermal Energy Storage Market with New IRS Tax Credit
VRAX

Business Wire

2 years ago

Brenmiller Energy See Massive Potential for U.S. Thermal Energy Storage Market with New IRS Tax Credit

PetVivo Holdings, Inc. Achieves Distribution Milestone Surpassing 4500 Syringes of Spryng™ in 2023
VRAX

GlobeNewswire

2 years ago

PetVivo Holdings, Inc. Achieves Distribution Milestone Surpassing 4500 Syringes of Spryng™ in 2023

Sonnet BioTherapeutics Announces Publication Demonstrating Suitability of SON-1210, the First Albumin-binding Bifunctional IL-12/IL-15 Fusion Protein, for Solid Tumor Immunotherapy
VRAX

ACCESSWIRE

2 years ago

Sonnet BioTherapeutics Announces Publication Demonstrating Suitability of SON-1210, the First Albumin-binding Bifunctional IL-12/IL-15 Fusion Protein, for Solid Tumor Immunotherapy

Virax Biolabs Forges Strategic Research Collaboration with University of Manchester and the Northern Care Alliance Foundation Trust to Enhance Understanding of Immune Responses in COVID Patients
VRAX

PR Newswire

2 years ago

Virax Biolabs Forges Strategic Research Collaboration with University of Manchester and the Northern Care Alliance Foundation Trust to Enhance Understanding of Immune Responses in COVID Patients

We're Not Very Worried About ARCA biopharma's (NASDAQ:ABIO) Cash Burn Rate
VRAX

Simply Wall St.

2 years ago

We're Not Very Worried About ARCA biopharma's (NASDAQ:ABIO) Cash Burn Rate

VRAX

GlobeNewswire

2 years ago

JE Cleantech Holdings Limited Announces Receipt of NASDAQ Notification Regarding Minimum Bid Price Deficiency

NUBURU Expands Automotive Manufacturing Offering with Wire Welding Solutions, Enabling High Yield Needed for Mass Production
VRAX

Business Wire

2 years ago

NUBURU Expands Automotive Manufacturing Offering with Wire Welding Solutions, Enabling High Yield Needed for Mass Production

Oxbridge Re announces the rebranding of its Corporate Website
VRAX

GlobeNewswire

2 years ago

Oxbridge Re announces the rebranding of its Corporate Website

Venus Concept Announces New International Distributors in the United Kingdom and India to Continue Global Growth
VRAX

GlobeNewswire

2 years ago

Venus Concept Announces New International Distributors in the United Kingdom and India to Continue Global Growth

Virax Biolabs' CEO James Foster Issues Letter to Shareholders
VRAX

PR Newswire

2 years ago

Virax Biolabs' CEO James Foster Issues Letter to Shareholders

Sonnet BioTherapeutics Provides Fiscal Year 2023 Business and Financial Update
VRAX

ACCESSWIRE

2 years ago

Sonnet BioTherapeutics Provides Fiscal Year 2023 Business and Financial Update

Virax Biolabs Group Limited Announces 1-for-10 Share Consolidation
VRAX

PR Newswire

2 years ago

Virax Biolabs Group Limited Announces 1-for-10 Share Consolidation

Avalo Encourages Stockholders to Vote FOR the Reverse Stock Split
VRAX

GlobeNewswire

2 years ago

Avalo Encourages Stockholders to Vote FOR the Reverse Stock Split

VRAX

GlobeNewswire

2 years ago

JE Cleantech (JCSE) Announces Annual General Meeting Results

BowFlex Inc. Announces Receipt of Continued Listing Standard Notice from NYSE
VRAX

Business Wire

2 years ago

BowFlex Inc. Announces Receipt of Continued Listing Standard Notice from NYSE

Quantum Myriad™ All-Flash File and Object Solution Now Generally Available
VRAX

PR Newswire

2 years ago

Quantum Myriad™ All-Flash File and Object Solution Now Generally Available

The Alkaline Water Company Receives Nasdaq Notice on Late Filing of Its Form 10-Q
VRAX

Business Wire

2 years ago

The Alkaline Water Company Receives Nasdaq Notice on Late Filing of Its Form 10-Q

New Real-World Data Highlight the Clinical Benefits of Ultrafiltration Therapy with Hematocrit Monitoring for Pediatric Patients
VRAX

GlobeNewswire

2 years ago

New Real-World Data Highlight the Clinical Benefits of Ultrafiltration Therapy with Hematocrit Monitoring for Pediatric Patients

SENSTAR MULTISENSOR™ INTRUSION DETECTION SYSTEM EARNS INDUSTRY RECONGNITION
VRAX

PR Newswire

2 years ago

SENSTAR MULTISENSOR™ INTRUSION DETECTION SYSTEM EARNS INDUSTRY RECONGNITION

Akari Therapeutics Presents Poster on Progress in Pre-Clinical Development of Long-Acting PAS-Nomacopan as a Potential Treatment for Geographic Atrophy at the 4th Annual Dry AMD Therapeutic Development Conference
VRAX

GlobeNewswire

2 years ago

Akari Therapeutics Presents Poster on Progress in Pre-Clinical Development of Long-Acting PAS-Nomacopan as a Potential Treatment for Geographic Atrophy at the 4th Annual Dry AMD Therapeutic Development Conference

Oxbridge Re Holdings Limited (NASDAQ:OXBR) Q3 2023 Earnings Call Transcript
VRAX

Insider Monkey

2 years ago

Oxbridge Re Holdings Limited (NASDAQ:OXBR) Q3 2023 Earnings Call Transcript

NUBURU Awarded Purchase Order from Major Multinational Electronics Manufacturer
VRAX

Business Wire

2 years ago

NUBURU Awarded Purchase Order from Major Multinational Electronics Manufacturer

OpGen Reports Third Quarter 2023 Financial Results and Provides Business Update
VRAX

GlobeNewswire

2 years ago

OpGen Reports Third Quarter 2023 Financial Results and Provides Business Update

Notable Labs Announces Filing of Form 10-Q for Third Quarter 2023
VRAX

GlobeNewswire

2 years ago

Notable Labs Announces Filing of Form 10-Q for Third Quarter 2023

Aptevo Therapeutics Reports 3Q23 Financial Results and Provides a Business Update
VRAX

ACCESSWIRE

2 years ago

Aptevo Therapeutics Reports 3Q23 Financial Results and Provides a Business Update

Vaccinex Reports Third Quarter 2023 Financial Results and Provides Corporate Update
VRAX

GlobeNewswire

2 years ago

Vaccinex Reports Third Quarter 2023 Financial Results and Provides Corporate Update

VYNE Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
VRAX

GlobeNewswire

2 years ago

VYNE Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update

NeoVolta Reports Q4 Sales Surge As Popular NV14 Home Solar Energy Storage Battery Shows Near Six-Figure Gross Revenues Over Last Six Weeks
VRAX

GlobeNewswire

2 years ago

NeoVolta Reports Q4 Sales Surge As Popular NV14 Home Solar Energy Storage Battery Shows Near Six-Figure Gross Revenues Over Last Six Weeks

Notable Labs Announces JCO Precision Oncology Publication Demonstrating PPMP Potential to Identify Novel Drug Combinations in JMML
VRAX

GlobeNewswire

2 years ago

Notable Labs Announces JCO Precision Oncology Publication Demonstrating PPMP Potential to Identify Novel Drug Combinations in JMML

Eledon Pharmaceuticals Reports Third Quarter 2023 Operating and Financial Results
VRAX

GlobeNewswire

2 years ago

Eledon Pharmaceuticals Reports Third Quarter 2023 Operating and Financial Results

LiqTech International Announces Third Quarter 2023 Financial Results
VRAX

PR Newswire

2 years ago

LiqTech International Announces Third Quarter 2023 Financial Results

Avalo Reports Third Quarter 2023 Financial Results and Provides Business Updates
VRAX

GlobeNewswire

2 years ago

Avalo Reports Third Quarter 2023 Financial Results and Provides Business Updates

Hanryu Holdings Launches Personalized Artificial Intelligence Assistant, DeokGom, on FANTOO in November
VRAX

ACCESSWIRE

2 years ago

Hanryu Holdings Launches Personalized Artificial Intelligence Assistant, DeokGom, on FANTOO in November

JE Cleantech Holdings Limited Regains Compliance with Nasdaq Minimum Bid Price Requirement
VRAX

NewMediaWire

2 years ago

JE Cleantech Holdings Limited Regains Compliance with Nasdaq Minimum Bid Price Requirement

Vaccinex Reports Clinical Benefit in Interim Analyses from two Phase 2 Studies of Pepinemab Combination Treatment at Society for Immunotherapy of Cancer’s Annual Meeting
VRAX

GlobeNewswire

2 years ago

Vaccinex Reports Clinical Benefit in Interim Analyses from two Phase 2 Studies of Pepinemab Combination Treatment at Society for Immunotherapy of Cancer’s Annual Meeting

Biotricity Releases Another Groundbreaking Product: Biotres Pro
VRAX

ACCESSWIRE

2 years ago

Biotricity Releases Another Groundbreaking Product: Biotres Pro

One Hall of Fame Resort & Entertainment Insider Raised Stake By 14% In Previous Year
VRAX

Simply Wall St.

2 years ago

One Hall of Fame Resort & Entertainment Insider Raised Stake By 14% In Previous Year

12 Best Dividend Stocks Under $5
VRAX

Insider Monkey

2 years ago

12 Best Dividend Stocks Under $5

Share on Social Networks: